The condition of a neonate with severe persistent pulmonary hypertension who became. severely hypoic and acidotic despite inteive conventional treatment improved dramatcally after endotracheal administration of tolazoline. This logical mode of adminitratWon of vasodilator therapy for this condiion has not been reportd before. It seemed to'be life saving in this case and it warrants fther clical ial. (Br HeartJ 1995;73:99-100) 
Persistent pulmonary hypertension of the newborn is primarily a disease of term and post term neonates and is characterised by severe pulmonary hypertension with right to left shunting across the atrial septum and the arterial duct. This produces marked hypoxaemia with a metabolic acidosis that in itself may provoke a further increase in pulmonary vascular resistance. The reported mortality associated with the condition ranges from 10% to 60%.12 The vasodilator tolazoline, given intravenously, is a widely used treatment3 but when pulmonary blood flow is low the drug may fail to reach the pulmonary capillary bed in therapeutic concentration. The failure of intravenous tolazoline in a severely hypoxic and acidotic neonate with persistent pulionary hypertension and the patient's apparently impending death led us to administer tolazoline directly into the bronchial tree via the endotracheal tube, a route of administration not previously reported. 
